Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

Pernix Therapeutics Holdings, Inc. (PTX)

-NasdaqGM
4.70 Up 0.38(8.80%) 4:00PM EDT
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Sep 30, 2013Jun 30, 2013Mar 31, 2013
Total Revenue 23,926   18,295   20,573   22,078  
Cost of Revenue10,059  9,572  11,162  13,077  
Gross Profit 13,867   8,723   9,411   9,000  
Operating Expenses
Research Development1,165  633  1,792  1,207  
Selling General and Administrative23,590  11,740  13,141  14,079  
Non Recurring -   -   -   -  
Others1,209  2,672  2,632  2,163  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (31,734) (6,318) (8,159) (8,449)
Income from Continuing Operations
Total Other Income/Expenses Net(5,612)(1,620)1,770  (1,858)
Earnings Before Interest And Taxes(17,710)(5,233)(9,093)(10,306)
Interest Expense557  3,492  (1,077)1,077  
Income Before Tax(18,267)(8,725)(8,017)(11,383)
Income Tax Expense(12,696)(2,676)(2,121)(3,263)
Minority Interest -   -   -   -  
Net Income From Continuing Ops(5,571)(6,049)(5,896)(8,120)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (5,571) (6,049) (5,896) (8,120)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (5,571) (6,049) (5,896) (8,120)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.